At ISSCR Lonza recently introduced its new L7™ hiPSC Reprogramming and hPSC Culture System for basic stem-cell research, disease modeling, drug development and regenerative medicine. The L7™ System will support the generation of reproducible, clinically relevant data as a solid basis for more efficient drug development and accelerated progress in regenerative medicine.
The innovative L7™ hiPSC Reprogramming and hPSC Culture System listed below include seven key components that are designed to work together as a robust workflow:
1. Clonetics™ and Poietics™ Primary Cells
2. Nucleofector™ Technology
3. L7TM Reprogramming Bundles for PBMCs and fibroblasts – coming soon
4. L7TM hPSC Medium
5. L7TM hPSC Matrix
6. L7TM hPC Passaging Solution
7. L7TM hPSC Cryosolution
This novel system is the only complete solution on the market for the generation of induced pluripotent stem-cells (iPSCs) as well as the maintenance of human embryonic stem-cells (hESCs) and iPSCs under defined, xeno-free conditions. The ...
